Rallybio (RLYB) Competitors

Adlai Nortye (NASDAQ:ANL) and Rallybio (NASDAQ:RLYB) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability and risk.

Which has better earnings and valuation, ANL or RLYB?

Adlai Nortye has higher revenue and earnings than Rallybio.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adlai Nortye	$5M	11.59	-$51.87M	N/A	N/A
Rallybio	$640K	26.92	-$57.78M	-$1.09	-0.38

Is ANL or RLYB more profitable?

Adlai Nortye has a net margin of 0.00% compared to Rallybio's net margin of -5,682.19%. Adlai Nortye's return on equity of 0.00% beat Rallybio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adlai Nortye	N/A	N/A	N/A
Rallybio	-5,682.19%	-72.31%	-64.78%

Do institutionals and insiders believe in ANL or RLYB?

35.2% of Adlai Nortye shares are held by institutional investors. Comparatively, 90.3% of Rallybio shares are held by institutional investors. 8.7% of Rallybio shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Do analysts recommend ANL or RLYB?

Adlai Nortye presently has a consensus price target of $9.00, indicating a potential upside of 473.25%. Rallybio has a consensus price target of $10.00, indicating a potential upside of 2,315.46%. Given Rallybio's higher possible upside, analysts clearly believe Rallybio is more favorable than Adlai Nortye.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adlai Nortye	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Rallybio	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Does the media favor ANL or RLYB?

In the previous week, Rallybio had 1 more articles in the media than Adlai Nortye. MarketBeat recorded 3 mentions for Rallybio and 2 mentions for Adlai Nortye. Adlai Nortye's average media sentiment score of 1.24 beat Rallybio's score of 0.56 indicating that Adlai Nortye is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Adlai Nortye	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Rallybio	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, ANL or RLYB?

Adlai Nortye has a beta of -0.95, meaning that its stock price is 195% less volatile than the S&P 500. Comparatively, Rallybio has a beta of -1.17, meaning that its stock price is 217% less volatile than the S&P 500.

Summary

Adlai Nortye beats Rallybio on 7 of the 12 factors compared between the two stocks.